Time-dependent systolic and diastolic function in mice overexpressing calcineurin.
暂无分享,去创建一个
H. Duff | D. Severson | J. Molkentin | L. Semeniuk | S. Swirp | A. Kryski
[1] D. Severson,et al. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. , 2002, American journal of physiology. Heart and circulatory physiology.
[2] Y. Takeishi,et al. Cardiac hypertrophy and failure: lessons learned from genetically engineered mice. , 2001, Acta physiologica Scandinavica.
[3] D. Kass,et al. Minimal force‐frequency modulation of inotropy and relaxation of in situ murine heart , 2001, The Journal of physiology.
[4] D. Burkhoff,et al. Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. , 2001, American journal of physiology. Heart and circulatory physiology.
[5] J. Molkentin,et al. Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway. , 2001, Journal of molecular and cellular cardiology.
[6] Mark A Sussman,et al. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. , 2000, Journal of molecular and cellular cardiology.
[7] A Haase,et al. Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. , 2000, American journal of physiology. Heart and circulatory physiology.
[8] Y. Zou,et al. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. , 1999, Circulation.
[9] O. Carretero,et al. Echocardiographic assessment of cardiac function in conscious and anesthetized mice. , 1999, American journal of physiology. Heart and circulatory physiology.
[10] E. Olson,et al. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. , 1999, Circulation research.
[11] M. Entman,et al. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. , 1998, The Journal of clinical investigation.
[12] Mark A Sussman,et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. , 1998, Science.
[13] J. Lorenz,et al. End-systolic stress-velocity and pressure-dimension relationships by transthoracic echocardiography in mice. , 1998, American journal of physiology. Heart and circulatory physiology.
[14] Jeffrey Robbins,et al. A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.
[15] G. Fishman,et al. The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. , 1998, Cardiovascular research.
[16] W. Colucci. Molecular and cellular mechanisms of myocardial failure. , 1997, The American journal of cardiology.
[17] M. Entman,et al. Noninvasive indexes of cardiac systolic and diastolic function in hyperthyroid and senescent mouse. , 1996, The American journal of physiology.
[18] R. Walsh,et al. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. , 1995, Circulation research.
[19] W. Little,et al. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. , 1994, Circulation.
[20] H. E. Keurs,et al. Excitation-contraction coupling in rat heart: influence of cyclosporin A. , 1993, Cardiovascular research.
[21] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[22] E. Starling,et al. The regulation of the heart beat , 1914, The Journal of physiology.